Lee Financial’s Kyntra Bio KYNB Stock Holding History

Lee Financial’s Portfolio KYNB Stock Details KYNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-57	Closed	-$20K	–	831
2021 Q4	$20K	Hold	57	–	–	﹤0.01%	370
2021 Q3	$15K	Sell	57 -64	-53%	-$22.7K	﹤0.01%	369
2021 Q2	$81K	Sell	121 -36	-23%	-$20.7K	0.02%	196
2021 Q1	$136K	Sell	157 -136	-46%	-$145K	0.03%	155
2020 Q4	$272K	Hold	293	–	–	0.07%	109
2020 Q3	$301K	Hold	293	–	–	0.08%	102
2020 Q2	$297K	Hold	293	–	–	0.08%	98
2020 Q1	$255K	Hold	293	–	–	0.08%	95
2019 Q4	$314K	Hold	293	–	–	0.07%	104
2019 Q3	$271K	Hold	293	–	–	0.06%	107
2019 Q2	$331K	Hold	293	–	–	0.07%	102
2019 Q1	$398K	Hold	293	–	–	0.09%	90
2018 Q4	$339K	Hold	293	–	–	0.09%	87
2018 Q3	$445K	Hold	293	–	–	0.11%	85
2018 Q2	$458K	Hold	293	–	–	0.11%	88
2018 Q1	$338K	Hold	293	–	–	0.09%	115
2017 Q4	$347K	Buy	+293	New	+$367K	0.1%	95

Other funds holding KYNB

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Lee Financial's KYNB Position: Q1 2022 in Review

Lee Financial sold out of Kyntra Bio (KYNB) in Q1 2022, closing a stake of 57 shares — an estimated $20K sold.

Lee Financial first reported a position in KYNB in Q4 2017 and held it in 17 quarters. The position peaked at $458K in Q2 2018. 156 funds tracked by Wall St. Rank hold KYNB as of Q1 2022.

Lee Financial reported no remaining Kyntra Bio position as of Q1 2022 after selling out during the quarter.
Lee Financial sold 57 Kyntra Bio shares in Q1 2022, an estimated $20K.
Lee Financial first reported a position in Kyntra Bio in Q4 2017 and held it in 17 quarters.
Lee Financial's Kyntra Bio position peaked at $458K in Q2 2018.
156 funds tracked by Wall St. Rank held Kyntra Bio as of Q1 2022.

Based on Lee Financial's 13F filing for Q1 2022, filed 11 May 2022.